QIFENG
873169
LEETRO
430425
KSEC Intelligent Technology
301311
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
688192 Dizal Pharmaceutical
- 52.23
- -4.15-7.36%
Market Closed May 12 15:00 CST
24.00BMarket Cap-29.48P/E (TTM)
55.00High51.58Low62.44KlotVolume55.00Open56.38Pre Close329.90MTurnover3.34%Turnover RatioLossP/E (Static)459.41MShares59.7152wk High13.39P/B9.75BFloat Cap32.7252wk Low67.66Limit Up186.71MShs Float59.71Historical High45.10Limit Down6.07%Amplitude19.02Historical Low--Dividend TTM52.84Avg Price31.67KlotAsk--Div YieldTTM100Lot Size24.44KlotBid
Dizal Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 70.21%164.19M | 682.09%436.63M | --351.2M | --185.03M | --96.46M | 637.58%55.83M | ---- | ---- | ---- | -26.60%7.57M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | -85.32%10.66M | -83.16%10.66M | -79.55%10.66M | --5.57M | 159.39%72.61M |
| Cash received relating to other operating activities | -11.73%25.29M | 33.48%48.47M | 134.96%36.77M | 138.44%34.66M | 416.41%28.65M | 78.51%36.31M | 131.35%15.65M | 280.26%14.54M | 542.83%5.55M | 66.27%20.34M |
| Cash inflows from operating activities | 51.45%189.48M | 371.90%485.1M | 1,374.84%387.97M | 771.96%219.69M | 1,025.12%125.11M | 2.27%102.8M | -66.11%26.31M | -60.33%25.2M | 31.87%11.12M | 98.90%100.52M |
| Goods services cash paid | 48.26%112.19M | -29.32%440.11M | -19.49%314.1M | -30.27%178.6M | -25.62%75.67M | 40.26%622.63M | 25.76%390.13M | 17.50%256.12M | -3.18%101.74M | 27.45%443.91M |
| Staff behalf paid | 12.45%158.49M | 45.30%478.16M | 52.66%360.38M | 50.10%245.3M | 48.09%140.95M | 65.66%329.1M | 59.04%236.07M | 54.17%163.42M | 66.29%95.18M | 38.67%198.66M |
| All taxes paid | 35.14%2.48M | 278.06%20.7M | 79.71%6.55M | 88.48%4.16M | 191.26%1.84M | 39.67%5.48M | 12.03%3.64M | -6.63%2.21M | -23.50%630.46K | 39.06%3.92M |
| Cash paid relating to other operating activities | 46.60%47.98M | 73.30%196.65M | 159.55%170.25M | 111.53%92.59M | 94.96%32.73M | 97.69%113.47M | 76.43%65.6M | 149.56%43.77M | -7.64%16.79M | 18.51%57.4M |
| Cash outflows from operating activities | 27.85%321.15M | 6.07%1.14B | 22.41%851.28M | 11.84%520.64M | 17.19%251.19M | 52.11%1.07B | 39.35%695.44M | 35.37%465.52M | 18.21%214.33M | 29.67%703.89M |
| Net cash flows from operating activities | -4.44%-131.67M | 32.79%-650.53M | 30.76%-463.31M | 31.65%-300.95M | 37.96%-126.07M | -60.41%-967.88M | -58.77%-669.13M | -57.06%-440.33M | -17.54%-203.21M | -22.57%-603.37M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -28.72%732.18M | -8.25%4.02B | -21.87%2.71B | -30.50%1.78B | -23.58%1.03B | -46.95%4.38B | -48.66%3.47B | -38.72%2.56B | -39.23%1.34B | 1,933.64%8.26B |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | ---- | ---- | -52.92%600 | ---- | ---- | ---- | --1.27K |
| Cash inflows from investing activities | -28.72%732.18M | -8.25%4.02B | -21.87%2.71B | -30.50%1.78B | -23.58%1.03B | -46.95%4.38B | -48.66%3.47B | -38.72%2.56B | -39.23%1.34B | 1,925.24%8.26B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 354.77%75.83M | 328.21%137.58M | 257.87%94.08M | 33.25%32.34M | 58.61%16.67M | -56.45%32.13M | -60.05%26.29M | -59.97%24.27M | 194.35%10.51M | 721.17%73.78M |
| Cash paid to acquire investments | -26.70%785M | 4.89%3.92B | -9.89%2.7B | -17.20%1.82B | -7.43%1.07B | -52.08%3.74B | -53.74%3B | -45.11%2.2B | -46.07%1.16B | 284.91%7.8B |
| Cash outflows from investing activities | -20.86%860.83M | 7.64%4.06B | -7.56%2.8B | -16.65%1.86B | -6.83%1.09B | -52.12%3.77B | -53.80%3.03B | -45.33%2.23B | -45.67%1.17B | 286.83%7.87B |
| Net cash flows from investing activities | -112.84%-128.65M | -106.23%-38.07M | -119.55%-86.62M | -122.71%-76.06M | -134.19%-60.44M | 58.93%611.19M | 113.94%443M | 214.09%334.86M | 179.77%176.81M | 123.63%384.56M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --100M | --100M | --100M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --100M | --100M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 71.37%391.34M | 184.82%963.36M | 251.88%703.48M | 421.62%415.46M | --228.36M | --338.23M | --199.92M | --79.65M | ---- | ---- |
| Cash received relating to other financing activities | ---- | 2,691.55%58.27M | 3,030.70%39.09M | 3,030.70%39.09M | 3,030.70%39.09M | -44.36%2.09M | --1.25M | --1.25M | --1.25M | -28.83%3.75M |
| Cash inflows from financing activities | 46.32%391.34M | 229.58%1.12B | 318.84%842.57M | 585.51%554.56M | 21,317.76%267.45M | 8,972.21%340.32M | --201.17M | --80.9M | --1.25M | -99.82%3.75M |
| Borrowing repayment | 147.03%112.67M | --203.73M | --201.63M | --127.12M | --45.61M | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | 177.71%9.06M | 508.17%20.55M | 858.22%12.76M | 3,072.20%7.67M | --3.26M | --3.38M | --1.33M | --241.71K | ---- | ---- |
| Cash payments relating to other financing activities | -36.42%7.01M | 5.71%30.33M | -10.66%21.38M | 8.79%14.32M | 6.60%11.02M | -22.49%28.69M | -23.75%23.94M | -49.29%13.16M | -43.67%10.34M | -8.39%37.02M |
| Cash outflows from financing activities | 114.95%128.73M | 693.88%254.61M | 833.11%235.77M | 1,012.46%149.11M | 479.44%59.89M | -13.36%32.07M | -19.51%25.27M | -48.36%13.4M | -43.67%10.34M | -38.31%37.02M |
| Net cash flows from financing activities | 26.52%262.62M | 181.27%867.01M | 244.97%606.8M | 500.72%405.45M | 2,384.36%207.57M | 1,026.65%308.25M | 660.35%175.9M | 360.05%67.49M | 50.47%-9.09M | -101.68%-33.26M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -29.44%41.82K | -352.24%-2.45M | 87.90%-247.85K | 108.91%203.78K | 106.56%59.27K | -89.80%971.24K | -116.46%-2.05M | -134.67%-2.29M | -36.76%-904.15K | 250.36%9.52M |
| Net increase in cash and cash equivalents | -88.91%2.34M | 470.66%175.96M | 208.33%56.63M | 171.15%28.64M | 158.01%21.11M | 80.43%-47.47M | 77.60%-52.28M | 79.15%-40.26M | 71.72%-36.39M | -67.54%-242.56M |
| Add:Begin period cash and cash equivalents | 238.02%249.89M | -39.10%73.93M | -39.10%73.93M | -39.10%73.93M | -39.10%73.93M | -66.65%121.4M | -66.65%121.4M | -66.65%121.4M | -66.65%121.4M | -28.46%363.96M |
| End period cash equivalent | 165.40%252.23M | 238.02%249.89M | 88.88%130.56M | 26.41%102.57M | 11.80%95.04M | -39.10%73.93M | -47.09%69.12M | -52.51%81.14M | -63.87%85.01M | -66.65%121.4M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.